[18F]ATX-1905

N/A

Report date: 2022/06/29 15:13:44
NME

Base Information

Drug Name[18F]ATX-1905
Drug Alias Name[18F]ATX-1905
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEctonucleotide pyrophosphatase/phosphodiesterase 2 inhibitorsPositron-emission tomography enhancers
TargetsEctonucleotide pyrophosphatase/phosphodiesterase 2
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesHarvard University
Inactive CompaniesN/A
Active IndicationsDiagnostic agents
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A